PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.75%
Operating income growth under 50% of 0354.HK's 77.13%. Michael Burry would be concerned about deeper cost or sales issues.
1.47%
Net income growth of 1.47% while 0354.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
4.63%
EPS growth under 50% of 0354.HK's 16.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.63%
Diluted EPS growth of 4.63% while 0354.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 0354.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.54%
10Y revenue/share CAGR under 50% of 0354.HK's 968.91%. Michael Burry would suspect a lasting competitive disadvantage.
57.54%
5Y revenue/share CAGR under 50% of 0354.HK's 222.62%. Michael Burry would suspect a significant competitive gap or product weakness.
59.81%
3Y revenue/share CAGR at 50-75% of 0354.HK's 88.72%. Martin Whitman would question if the firm lags behind competitor innovations.
1210.34%
10Y OCF/share CAGR under 50% of 0354.HK's 3141.82%. Michael Burry would worry about a persistent underperformance in cash creation.
1210.34%
5Y OCF/share CAGR above 1.5x 0354.HK's 730.13%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1077.47%
3Y OCF/share CAGR above 1.5x 0354.HK's 8.12%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
138.06%
Below 50% of 0354.HK's 277.91%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
138.06%
5Y net income/share CAGR at 50-75% of 0354.HK's 188.47%. Martin Whitman might see a shortfall in operational efficiency or brand power.
77.49%
3Y net income/share CAGR above 1.5x 0354.HK's 44.43%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while 0354.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
42.68%
We show growth while 0354.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
35.24%
Asset growth above 1.5x 0354.HK's 9.14%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
10.05%
Under 50% of 0354.HK's 28.42%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
9.48%
Debt growth far above 0354.HK's 17.52%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.